Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin

  • R. Draenert
  • M. Kunzelmann
  • A. Roggenkamp
  • J. Hellers
  • J. R. BognerEmail author
Brief Report

The existing medical literature contains, to the best of our knowledge, no published reports on the efficacy of moxifloxacin in treating infected cat-bite wounds. Nevertheless, in vitro data regarding the sensitivity of typical bite-wound bacteria to moxifloxacin encourage the use of this antibiotic [1, 2]. The high bactericidal activity of moxifloxacin against gram-positive, gram-negative and several anaerobic organisms in conjunction with data on tissue availability of the compound led Bayer Pharmaceuticals to perform two large-scale multicenter trials with moxifloxacin in severe skin and soft tissue infections between 2001 and 2004 (personal communication); however, the results are not yet available. In a study of non-complicated skin and soft tissue infections, moxifloxacin was found to be equivalent to cephalexin in the treatment of cellulitis and skin infections [3]. In the case presented here, an infected cat-bite wound was successfully treated with intravenous followed by oral...


Moxifloxacin Cefuroxime Talan Antimicrobial Regimen Streptococcus Viridans 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Goldstein EJ, Citron DM, Hudspeth M, Hunt-Gerardo S, Merriam CV (1997) In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans. Antimicrob Agents Chemother 41:1552–1557Google Scholar
  2. 2.
    Talan DA, Abrahamian FM, Moran GJ, Citron DM, Tan JO, Goldstein EJ (2003) Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments. Clin Infect Dis 37:1481–1489Google Scholar
  3. 3.
    Parish LC, Routh HB, Miskin B, Fidelholtz J, Werschler P, Heyd A, Haverstock D, Church D (2000) Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections. Int J Clin Pract 54:497–503Google Scholar
  4. 4.
    Talan DA, Citron DM, Abrahamian FM, Moran GJ, Goldstein EJC (1999) Bacteriologic analysis of infected dog and cat bites. N Engl J Med 340:85–92Google Scholar
  5. 5.
    Vree TB, Hekster YA (1990) Pharmacokinetics and tissue concentrations of cefuroxime. Pharm Weekbl Sci Ed 12:262–267Google Scholar
  6. 6.
    Brunner M, Stabeta H, Moller JG, Schrolnberger C, Erovic B, Hollenstein U, Zeitlinger M, Eichler HG, Muller M (2002) Target site concentrations of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother 46:3724–3730Google Scholar
  7. 7.
    Joukhadar C, Stass H, Muller-Zellenberg U, Lackner E, Kovar F, Minar E, Muller M (2003) Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. Antimicrob Agents Chemother 47:3099–3103Google Scholar
  8. 8.
    Hall IH, Schwab UE, Ward ES, Ives T (2003) Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions. Int J Antimicrob Agents 22:579–587Google Scholar
  9. 9.
    Kelly IP, Cunney RJ, Smyth EG, Colville J (1996) The management of human bite injuries of the hand. Injury 27:481–484Google Scholar

Copyright information

©  2005

Authors and Affiliations

  • R. Draenert
    • 1
  • M. Kunzelmann
    • 2
  • A. Roggenkamp
    • 3
  • J. Hellers
    • 2
  • J. R. Bogner
    • 1
    Email author
  1. 1.Medizinische Poliklinik, Department of Infectious DiseasesUniversity Hospital of MunichMunichGermany
  2. 2.Department of Hand SurgeryUniversity Hospital of MunichMunichGermany
  3. 3.Department of BacteriologyMax von Pettenkofer InstituteMunichGermany

Personalised recommendations